SELENOP may modify cardiovascular disease risk by several mechanisms [26]: It transports selenium to vital tissues that are equipped with receptors (megalin or APOER2) for SELENOP uptake, thereby increasing intracellular selenoprotein biosynthesis for improving antioxidative defense and protein quality control systems [12]. The gene discussed is LRP2; the disease is cardiovascular disorder.